Journal of Virology · 2007 · 31 citations · 22 references
Life SciencesCell BiologyMolecular BiologyCell SignalingGene ExpressionMolecular VirologyCyclin-dependent KinasesNuclear-cytoplasmic TransportCdk InhibitorsCyclin-dependent Kinase ComplexesCyclin-dependent Kinase InhibitorsCyclin-dependent Kinase PhosphorylationNuclear Export Of Host Antiviral FactorsNuclear Export PathwaysProtein Nuclear ExportTreatment Of Cytomegalovirus Infection
We have previously shown that treatment of human cytomegalovirus-infected cells with the cyclin-dependent kinase (cdk) inhibitor roscovitine has significant effects on several stages of the virus life cycle depending on the time of addition (V. Sanchez, A. K. McElroy, J. Yen, S. Tamrakar, C. L. Clark, R. A. Schwartz, and D. H. Spector, J. Virol. 78:11219-11232, 2004; V. Sanchez and D. Spector, J. Virol. 80:5886-5896, 2006). In this report, we add to these findings by demonstrating alterations in the phosphorylation and localization of pp65 (UL83) in cells treated with roscovitine. We observed that inhibition of cdk activity causes the retention of pp65 within the nucleus at late times postinfection. At the same time, we observed a change in the phosphorylation pattern of the protein. Interestingly, mutation of potential cdk phosphorylation sites did not affect the ability of pp65 to localize to the nucleus or to relocalize to the cytoplasm late in infection. However, we found that the cytoplasmic accumulation of pp65 late in infection was sensitive to the Crm1 inhibitor leptomycin B.
22
Verónica Sánchez, Kenneth D. Greis, Elizabeth Sztul et al. · Journal of Virology · 2000 · 346 citations
Inhibition of Cellular Cdk2 Activity Blocks Human Cytomegalovirus Replication
Wade A. Bresnahan, István Boldogh, Ping Chi et al. · Virology · 1997 · 143 citations